Trial
NCT01813214
The Effects of Vemurafenib + Cobimetinib on Immunity in Patients With Melanoma
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Georgetown University
Collaborators
Genentech, Inc.; Melanoma Research Alliance
Condition
Melanoma
Intervention
Vemurafenib
Why stopped
Recruitment difficulties.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-02-26